Repigmentation of Tenacious Vitiligo on Apremilast.

Case Rep Dermatol Med · 2017 · PMC5694993 · PMID 29234546

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

fairly significantno p-value reported

At her next follow-up, 8 months after beginning apremilast treatment, the patient experienced fairly significant repigmentation.

also in 581 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.